Marathon Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $419K | Sell |
3,315
-300
| -8% | -$38K | 0.11% | 107 |
|
|
2025
Q1 | $462K | Hold |
3,615
| – | – | 0.12% | 98 |
|
|
2024
Q4 | $478K | Hold |
3,615
| – | – | 0.12% | 96 |
|
|
2024
Q3 | $526K | Hold |
3,615
| – | – | 0.13% | 92 |
|
|
2024
Q2 | $496K | Hold |
3,615
| – | – | 0.13% | 92 |
|
|
2024
Q1 | $496K | Hold |
3,615
| – | – | 0.12% | 94 |
|
|
2023
Q4 | $491K | Hold |
3,615
| – | – | 0.12% | 97 |
|
|
2023
Q3 | $442K | Sell |
3,615
-200
| -5% | -$24.5K | 0.11% | 96 |
|
|
2023
Q2 | $484K | Sell |
3,815
-100
| -3% | -$12.7K | 0.12% | 96 |
|
|
2023
Q1 | $506K | Sell |
3,915
-200
| -5% | -$25.8K | 0.12% | 98 |
|
|
2022
Q4 | $540K | Buy |
4,115
+100
| +2% | +$13.1K | 0.15% | 89 |
|
|
2022
Q3 | $470K | Buy |
+4,015
| New | +$470K | 0.13% | 98 |
|
|
2022
Q1 | – | Sell |
-3,715
| Closed | -$567K | – | 127 |
|
|
2021
Q4 | $567K | Sell |
3,715
-600
| -14% | -$91.6K | 0.13% | 99 |
|
|
2021
Q3 | $698K | Sell |
4,315
-500
| -10% | -$80.9K | 0.16% | 89 |
|
|
2021
Q2 | $787K | Hold |
4,815
| – | – | 0.18% | 72 |
|
|
2021
Q1 | $724K | Hold |
4,815
| – | – | 0.19% | 67 |
|
|
2020
Q4 | $729K | Sell |
4,815
-100
| -2% | -$15.1K | 0.21% | 65 |
|
|
2020
Q3 | $665K | Hold |
4,915
| – | – | 0.24% | 64 |
|
|
2020
Q2 | $672K | Buy |
+4,915
| New | +$672K | 0.26% | 56 |
|